These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16211089)

  • 21. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.
    Zimmer M; Doucette D; Siddiqui N; Iliopoulos O
    Mol Cancer Res; 2004 Feb; 2(2):89-95. PubMed ID: 14985465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The von Hippel-Lindau tumor suppressor gene.
    Kondo K; Kaelin WG
    Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.
    Jones MK; Szabó IL; Kawanaka H; Husain SS; Tarnawski AS
    FASEB J; 2002 Feb; 16(2):264-6. PubMed ID: 11772947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis.
    Fu R; Chen Y; Wang XP; An T; Tao L; Zhou YX; Huang YJ; Chen BA; Li ZY; You QD; Guo QL; Wu ZQ
    Oncotarget; 2016 Feb; 7(5):5715-27. PubMed ID: 26735336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination.
    Jung JE; Kim HS; Lee CS; Shin YJ; Kim YN; Kang GH; Kim TY; Juhnn YS; Kim SJ; Park JW; Ye SK; Chung MH
    Exp Mol Med; 2008 Oct; 40(5):479-85. PubMed ID: 18985005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
    Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis].
    Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low frequency of HIF-1α overexpression in germ cell tumors of the testis.
    Vranic S; Hes O; Grossmann P; Gatalica Z
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):165-9. PubMed ID: 22820662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
    Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
    Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene transfer of von Hippel-Lindau inhibits the growth of transplanted solid tumors].
    Sun XY; Wang JL; Tang B; Liu FJ; Qiao HQ; Jiang HC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):241-4. PubMed ID: 16167238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.
    Chen L; Han L; Zhang K; Shi Z; Zhang J; Zhang A; Wang Y; Song Y; Li Y; Jiang T; Pu P; Jiang C; Kang C
    Neuro Oncol; 2012 Aug; 14(8):1026-36. PubMed ID: 22649212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation.
    Xue Y; Bi F; Zhang X; Zhang S; Pan Y; Liu N; Shi Y; Yao X; Zheng Y; Fan D
    Int J Cancer; 2006 Jun; 118(12):2965-72. PubMed ID: 16395716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.
    Kaelin WG
    Cold Spring Harb Symp Quant Biol; 2005; 70():159-66. PubMed ID: 16869749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation.
    Zhao D; Zheng S; Wang X; Liu H; Zhao K; Li L; Hu Y
    Oncogene; 2022 Mar; 41(13):1944-1958. PubMed ID: 35169254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel VHL target genes and relationship to hypoxic response pathways.
    Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
    Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation.
    Fu C; Tyagi R; Chin AC; Rojas T; Li RJ; Guha P; Bernstein IA; Rao F; Xu R; Cha JY; Xu J; Snowman AM; Semenza GL; Snyder SH
    Circ Res; 2018 Feb; 122(3):457-472. PubMed ID: 29279301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
    Turcotte S; Desrosiers RR; Beliveau R
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.